Skip to main content
Back to General Catalyst

General Catalyst's Pharmaceutical Portfolio

Browse 5 Pharmaceutical companies funded by General Catalyst. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
5
Total Funding in Pharmaceutical
$601.6M

Pharmaceutical Portfolio Companies (5)

Export
Health CareMedicalPharmaceutical

Judi Health is a healthtech platform that provides pharmacy benefit management solutions.

New York, United States
September 2025
$252.0M
Series F

Founder Contacts

30,000+ verified contacts

Health CareLife SciencePersonal HealthPharmaceutical

Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs.

New York, United States
September 2021
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalPrecision Medicine

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Cambridge, United States
June 2026
$75.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceOncologyPharmaceutical

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

Pennsylvania Furnace, United States
May 2026
$250.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyPharmaceutical

Manas AI is a disruptive drug development AI firm that offers drugs for cancer and rare diseases.

San Francisco, United States
January 2025
$24.6M
Seed

Founder Contacts

30,000+ verified contacts

Explore General Catalyst's Full Portfolio

View all companies funded by General Catalyst across every industry and funding stage.

View Full General Catalyst Portfolio